<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03890718</url>
  </required_header>
  <id_info>
    <org_study_id>ShaheidBU</org_study_id>
    <nct_id>NCT03890718</nct_id>
  </id_info>
  <brief_title>Stromal Enhancement in Keratoconus, Using Stromal Lenticules of Myopic SMILE Patients (Simultaneously)</brief_title>
  <acronym>keratoconus</acronym>
  <official_title>Stromal Enhancement in Keratoconus, Using Stromal Lenticules of Myopic SMILE Patients (Simultaneously)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shahid Beheshti University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shahid Beheshti University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the feasibility, safety, and efficacy of using a donor lenticule created
      during small incision lenticule extraction (SMILE) in patients with advance keratoconus
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">March 30, 2019</start_date>
  <completion_date type="Anticipated">December 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>visual acuity</measure>
    <time_frame>6 months</time_frame>
    <description>Visual acuity (VA) commonly refers to the clarity of vision</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">22</enrollment>
  <condition>Keratoconus</condition>
  <arm_group>
    <arm_group_label>Donat lenticul</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Simultaneous Lenticule Impanation (SLI)</intervention_name>
    <description>Increase cornea stromal thickness in patients with advance ectasia by donor lenticule created during small incision lenticule extraction (SMILE)</description>
    <arm_group_label>Donat lenticul</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  visual dissatisfaction with spectacles

          -  contact lens intolerance

          -  Age of ≥ 21 years

          -  Best Corrected Distance Visual Acuity (BCDVA) log MAR 0.6 (equivalent 20/40)

          -  Maximum of 50 diopters of keratometry

          -  Intraocular Pressure (IOP) of less than 20 mm Hg

          -  corneal endothelial cell density proportional to the patient's age of at least 2000
             mm²

        Exclusion Criteria:

          -  History of previous intraocular surgery

          -  History of herpetic corneal infections

          -  The presence of ocular diseases, such as glaucoma, active vernal
             kerato-conjunctivitis, intraocular inflammation, and retinal diseases except for KCN

          -  Histories of systemic diseases, such as diabetes mellitus, immune deficiency, and
             collagen vascular disease, which could delay corneal wound healing

          -  Drug history of sumatriptan, amiodarone, and isotretinoin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jorge Alio, MD,PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Division of Ophthalmology, Universidad Miguel Hernández, Alicante, Spain</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Farideh Doroodgar</name>
      <address>
        <city>Tehran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>March 25, 2019</study_first_submitted>
  <study_first_submitted_qc>March 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 26, 2019</study_first_posted>
  <last_update_submitted>June 25, 2020</last_update_submitted>
  <last_update_submitted_qc>June 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shahid Beheshti University</investigator_affiliation>
    <investigator_full_name>farinaz doroodgar</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

